Figure 21 is titled “Loss of PTSD diagnosis for narrative exposure therapy compared with inactive controls.” The figure displays a forest plot reporting risk difference in loss of PTSD diagnosis, narrative exposure therapy compared with inactive controls. Data for Figure 21 are presented in Appendix F. This figure is described further in the “Loss of PTSD Diagnosis” section as follows: “Our meta-analysis found that 15 percent more subjects were no longer diagnosed with PTSD at the end of treatment for narrative exposure therapy than for inactive comparator groups.” Overall risk difference was 0.15 (95% CI 0.01 to 0.30). Overall I2 = 48.1%.

Figure 21Loss of PTSD diagnosis for narrative exposure therapy compared with inactive controls

Note: Neuner, 2010, reported loss of diagnosis at 6-months; Neuner, 2008, at 9-months; and Neuner, 2004, at one-year.

From: Results

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.